Related Experiment Video
Updated: Jul 24, 2025
04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
726
Unicystic ameloblastoma - A case series
Arulmozhi M Rajasekaran1, Cheruvathur Prasad1, J Balaji1
1Department of Oral and Maxillofacial Surgery, Tamil Nadu Government Dental College and Hospital, Chennai, Tamil Nadu, India.
Summary
Unicystic ameloblastoma, a jaw tumor, can be treated with enucleation and curettage, preserving mandibular continuity. This minimally invasive approach showed no recurrence in a 3.5-5 year follow-up.
Area of Science:
- Oral and Maxillofacial Surgery
- Oncology
- Pathology
Background:
- Ameloblastoma is a benign, locally aggressive jaw neoplasm (1-3% of jaw tumors).
- Standard treatment involves wide surgical excision with a safe margin.
- This study explores conservative management of unicystic ameloblastoma to preserve mandibular integrity.
Observation:
- The study included patients aged 18-40 years, both sexes, with mandibular unicystic ameloblastoma.
- A male predilection was observed for this specific type and location.
- All cases were treated via enucleation and curettage, avoiding resection.
Findings:
- No post-operative paresthesia was reported in any patient.
- Surgical recovery was uneventful for all treated individuals.
- A follow-up period of 3.5-5 years revealed no instances of tumor recurrence.
Implications:
- Enucleation and curettage offer a viable, conservative alternative for managing unicystic ameloblastoma.
- This approach successfully preserves mandibular continuity and function.
- Minimally invasive treatment may reduce morbidity associated with traditional resection methods.
